已发表论文

Circ-SAR1A 通过 miR-382/YBX1 轴促进肾细胞癌的发展

 

Authors Zhao X, Zhao Z, Xu W, Liu H, Chang J, Xu W, Li S, Cao S, Hou J

Received 14 January 2020

Accepted for publication 30 June 2020

Published 18 August 2020 Volume 2020:12 Pages 7353—7361

DOI https://doi.org/10.2147/CMAR.S245918

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Beicheng Sun

Background: Accumulating evidence points to a role for circular RNAs (circRNAs) in important regulatory function in tumor advancement. We explored the effect and function of circ-SAR1A in renal cell carcinoma (RCC).
Methods: circ-SAR1A expression in RCC tissues and cell lines was explored by qRT-PCR. The roles of circ-SAR1A on RCC progression were explored by in vitro function assays. Moreover, we determined the underlying mechanism of circ-SAR1A in RCC progression through bioinformatics analysis and dual-luciferase reporter assays.
Results: Our data reveal that circ-SAR1A is significantly high in RCC tissues and cell lines. High circ-SAR1A levels are correlated to advanced Fuhrman grade, and lymph-node metastasis in RCC patients. Functional experiments indicate that circ-SAR1A suppression decreased RCC cell growth and invasion abilities in vitro. Mechanistically, circ-SAR1A upregulated YBX1 expression by sponging miR-382, resulting in promoting the growth and invasion in RCC cells.
Conclusion: Our data indicate that the circ-SAR1A/miR-382/YBX1 axis plays a critical role in RCC progression, which serve as a potential novel treatment strategy of RCC.
Keywords: circ-SAR1A, miR-382, YBX1, renal cell carcinoma




Figure 3 Direct interaction of circ-SAR1A with miR-382...